News - Oncolytic virus
2012-06-04 02:25:26
CHICAGO, June 4, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic
2012-05-28 22:20:44
HELSINKI, Finland, May 29, 2012 /PRNewswire/ -- Oncos Therapeutics today announced the successful initiation of its Phase I clinical study of CGTG-102, an oncolytic adenovirus
2012-05-16 14:22:25
SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire/ -- Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted
2012-04-03 10:09:24
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection.
